Rivamer 3 mg (Rivastigmine) Sematrinity 4mg which promote insulin release and

which promote insulin release and decrease glucagon secretion in a glucose-dependent manner

Rifaximin belongs to the rifamycin class of antibiotics but is distinguished by its minimal systemic absorption

Maximum 4 tablets (650 mg each) in 24 hours with at least 4–6 hours between doses

Consult your physician for detailed dosing tailored to your health status

May cause drowsiness—avoid driving or heavy machinery

Rivamer 3 mg (Rivastigmine) Sematrinity 4mg which promote insulin release andRivamer 3 mg (Rivastigmine) Product Information Rivamer 3 mg (Rivastigmine) Product Overview Rivamer 3 mg is a prescription medication that contains the active ingredient rivastigmine. It belongs to a class of drugs known as cholinesterase inhibitors and is used primarily in the management of cognitive decline associated with Alzheimer's disease and dementia related to Parkinson's disease. The product is manufactured by Sun Pharmaceutical Industries